June 1, 2021 ~ TrialSite News
Fact-Checking the Fact-Checkers Yet Again: This Time on the Potential Association of Ivermectin to the Dramatic Decrease in COVID-19 Cases in India
A TrialSite community member recently submitted an entry associated with a purported “fact checker” seeking to squash any possible linkage of the dramatic turnaround in cases in Indian states such as Uttar Pradesh with the population-wide use of ivermectin. TrialSite includes the entry authored by a group affiliated with British Ivermectin Recommendation Development (BIRD). On the 17th of May, Jim Hoft published on his blog page a short article titled “Elites Worried: Covid Cases in India Plummet after Government Promotes Ivermectin and Hydroxychloroquine use”. He reportsm “The India health ministry updated its guidelines on April 28 for quarantines, treating the asymptomatic and those with mild symptoms of COVID-19. The agency now says that asymptomatic patients should “consider Ivermectin (200 mcg/kg once a day, to be taken on an empty stomach) for 3 to 5 days.” Caregivers of patients in quarantine are instructed to “take Hydroxychloroquine prophylaxis as per protocol and as prescribed by the treating medical officer.” An article authored by Pablo Rougerie at the “Fact Checking” Health Feedback declared in response there is no data to justify such a link. But are the fact-checkers in fact correct? Or do they represent a particular bias or point of view and hence are more measured in what they purport as truth?
Anyone can check the World Coronavirus data on India and can see that Covid cases have been falling dramatically since the beginning of May. If you have any misgivings about Mr, Hoft’s little dig at the “Worried Elites” there is not much else to disagree with here.
And along comes Pablo Rougerie of the “Fact Checking” Health Feedback website, claiming there is “No data available to suggest a link between India’s reduction of Covid-19 cases and the use of ivermectin.”